INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor modelsPhillip C.C. Liu, Gregory Hollis|PLoS ONE|2020Cited by 160
Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease SeverityPhillip C.C. Liu, Jordan S. Fridman|Clinical Cancer Research|2009Cited by 19